دورية أكاديمية
Urine microbiome in individuals with an impaired immune system.
| العنوان: | Urine microbiome in individuals with an impaired immune system. |
|---|---|
| المؤلفون: | Elsayed NS; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, United States., Wolfe AJ; Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, United States., Burk RD; Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY, United States.; Departments of Microbiology and Immunology, Epidemiology and Population Health, and Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, NY, United States. |
| المصدر: | Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2024 Jan 11; Vol. 13, pp. 1308665. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2023). |
| نوع المنشور: | Journal Article; Review; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Media SA |
| مواضيع طبية MeSH: | Urinary Tract* , Microbiota* , Urinary Tract Infections*, Humans ; Dysbiosis ; Immune System |
| مستخلص: | With the advent of next generation sequencing, it is now appreciated that human urine is not sterile. Recent investigations of the urinary microbiome (urobiome) have provided insights into several urological diseases. Urobiome dysbiosis, defined as non-optimal urine microbiome composition, has been observed in many disorders; however, it is not clear whether this dysbiosis is the cause of urinary tract disorders or a consequence. In addition, immunologically altered disorders are associated with higher rates of urinary tract infections. These disorders include immunoproliferative and immunodeficiency diseases, cancer, and immunosuppressant therapy in transplant recipients. In this review, we examine the current state of knowledge of the urobiome in immunologically altered diseases, its composition and metabolomic consequences. We conclude that more data are required to describe the urobiome in immune altered states, knowledge that could facilitate understanding the role of the urobiome and its pathophysiological effects on urinary tract infections and other disorders of the urinary tract. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 Elsayed, Wolfe and Burk.) |
| References: | Microbiol Spectr. 2023 Jun 15;11(3):e0366222. (PMID: 37227288) Am J Transplant. 2013 Jun;13(6):1474-83. (PMID: 23721552) Sci Rep. 2019 Sep 16;9(1):13409. (PMID: 31527753) J Clin Invest. 1993 Jan;91(1):69-76. (PMID: 8423234) Diabetes Res Clin Pract. 2014 Mar;103(3):373-81. (PMID: 24529566) J Gen Virol. 2018 Aug;99(8):1141-1146. (PMID: 29889019) Sci Transl Med. 2013 May 8;5(184):184ra60. (PMID: 23658245) Arthritis Res Ther. 2014 Jan 06;16(1):R3. (PMID: 24387619) Front Microbiol. 2015 Jan 23;6:14. (PMID: 25667584) PLoS One. 2019 Mar 6;14(3):e0212434. (PMID: 30840641) Front Med (Lausanne). 2018 Aug 10;5:223. (PMID: 30159314) Prostate. 2019 Jan;79(1):81-87. (PMID: 30117171) Can Urol Assoc J. 2013 Nov-Dec;7(11-12):E740-9. (PMID: 24282468) Lancet. 2016 Dec 3;388(10061):2796-2810. (PMID: 27345655) Commun Biol. 2019 Aug 5;2:291. (PMID: 31396571) Microbiol Spectr. 2022 Oct 26;10(5):e0021222. (PMID: 35913213) J Egypt Natl Canc Inst. 2020 Nov 30;32(1):44. (PMID: 33252773) J Intern Med. 2015 Oct;278(4):369-95. (PMID: 26212387) Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E592-600. (PMID: 24367088) Clin Dev Immunol. 2006 Mar;13(1):41-8. (PMID: 16603443) Int J Cancer. 2015 Mar 1;136(5):E359-86. (PMID: 25220842) Nat Rev Urol. 2014 Mar;11(3):153-62. (PMID: 24492433) Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6036-41. (PMID: 22492977) Biochim Biophys Acta. 2014 Nov;1839(11):1217-1225. (PMID: 25072865) J Urol. 2020 Aug;204(2):303-309. (PMID: 32118507) Trends Microbiol. 2017 Mar;25(3):182-191. (PMID: 27914761) Nat Commun. 2019 Dec 4;10(1):5521. (PMID: 31797927) Transplantation. 2013 Oct 27;96(8):732-8. (PMID: 23917724) J Clin Microbiol. 2012 Apr;50(4):1376-83. (PMID: 22278835) Transpl Infect Dis. 2018 Apr;20(2):e12828. (PMID: 29272071) Urol Int. 1992;48(2):235-8. (PMID: 1316664) Ann Rheum Dis. 1995 Mar;54(3):216-20. (PMID: 7748019) J Bacteriol. 2018 Mar 12;200(7):. (PMID: 29378882) Am J Obstet Gynecol. 2015 Sep;213(3):347.e1-11. (PMID: 26210757) J Clin Microbiol. 2016 May;54(5):1216-22. (PMID: 26962083) Front Cell Infect Microbiol. 2022 Jun 09;12:860408. (PMID: 35755842) Front Cell Infect Microbiol. 2020 Dec 15;10:555508. (PMID: 33384966) Transplantation. 2014 Oct 15;98(7):697-705. (PMID: 25289916) Reprod Sci. 2013 Jul;20(7):791-6. (PMID: 23202727) Am J Infect Control. 2016 Nov 1;44(11):1261-1268. (PMID: 27311513) PLoS One. 2010 Mar 24;5(3):e9836. (PMID: 20352091) Cell Host Microbe. 2020 Aug 12;28(2):298-305.e3. (PMID: 32697939) J Infect Dis. 2009 Mar 15;199(6):837-46. (PMID: 19434930) J Transl Med. 2012 Aug 28;10:174. (PMID: 22929533) J Clin Invest. 1990 Jan;85(1):62-7. (PMID: 2404029) Curr Bladder Dysfunct Rep. 2016 Mar;11(1):18-24. (PMID: 27182288) J Immunol Res. 2018 Mar 15;2018:5841031. (PMID: 29736405) J Natl Cancer Inst. 2011 Dec 21;103(24):1827-39. (PMID: 22158127) Am J Obstet Gynecol. 2020 Feb;222(2):154.e1-154.e10. (PMID: 31421123) J Am Soc Nephrol. 2007 Nov;18(11):2810-6. (PMID: 17942949) Sci Rep. 2016 Sep 16;6:33327. (PMID: 27633952) BMC Nephrol. 2020 Apr 6;21(1):117. (PMID: 32252662) Life (Basel). 2021 Nov 19;11(11):. (PMID: 34833140) Am J Transplant. 2004 Aug;4(8):1289-95. (PMID: 15268730) mBio. 2020 Apr 28;11(2):. (PMID: 32345639) Clin Microbiol Rev. 1992 Jul;5(3):262-74. (PMID: 1323383) Curr Opin Nephrol Hypertens. 2019 Jan;28(1):65-69. (PMID: 30320619) J Clin Microbiol. 2014 Mar;52(3):871-6. (PMID: 24371246) Br Med J. 1881 Oct 15;2(1085):623-5. (PMID: 20750001) Front Cell Infect Microbiol. 2021 May 18;11:617002. (PMID: 34084752) PLoS Negl Trop Dis. 2012;6(11):e1912. (PMID: 23209855) Sci Rep. 2018 Aug 14;8(1):12157. (PMID: 30108246) Front Cell Infect Microbiol. 2018 May 31;8:167. (PMID: 29904624) Cell Host Microbe. 2016 Aug 10;20(2):215-25. (PMID: 27512904) Ann Rheum Dis. 1970 Mar;29(2):143-8. (PMID: 4913484) Sci Rep. 2021 Jan 26;11(1):2212. (PMID: 33500504) Ann Rheum Dis. 1992 May;51(5):604-6. (PMID: 1616323) mBio. 2019 Aug 27;10(4):. (PMID: 31455657) Sci Rep. 2020 Jul 6;10(1):11042. (PMID: 32632181) Oncotarget. 2017 Sep 21;8(59):100678-100690. (PMID: 29246012) Nat Rev Dis Primers. 2018 Feb 08;4:18001. (PMID: 29417936) Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4680-7. (PMID: 20534435) Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:126-129. (PMID: 29936400) Am J Transplant. 2014 Feb;14(2):416-27. (PMID: 24373208) Sci Rep. 2016 Apr 22;6:24380. (PMID: 27103314) mBio. 2014 Jul 08;5(4):e01283-14. (PMID: 25006228) BMJ Open Gastroenterol. 2017 Jul 3;4(1):e000145. (PMID: 28944067) Transl Res. 2017 Mar;181:59-70. (PMID: 27669488) Biomed Pharmacother. 2017 May;89:918-925. (PMID: 28292019) Int Urogynecol J. 2018 Dec;29(12):1797-1805. (PMID: 30267143) J Bacteriol. 2021 Sep 8;203(19):e0036021. (PMID: 34280003) Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2461-2466. (PMID: 29467286) Toxins (Basel). 2018 Jan 11;10(1):. (PMID: 29324646) Clin Exp Immunol. 2009 Jan;155(1):1-15. (PMID: 19076824) Nat Rev Urol. 2015 Feb;12(2):81-90. (PMID: 25600098) Front Med (Lausanne). 2018 Apr 19;5:72. (PMID: 29725592) Mol Carcinog. 2016 May;55(5):514-24. (PMID: 25789966) Microbiol Spectr. 2024 Jan 11;12(1):e0263823. (PMID: 38088549) Nat Rev Urol. 2018 Dec;15(12):735-749. (PMID: 30315209) Rheum Dis Clin North Am. 1998 May;24(2):423-56. (PMID: 9606766) J Urol. 2018 Jan;199(1):161-171. (PMID: 28797714) Nat Rev Microbiol. 2023 Jan;21(1):51-64. (PMID: 35931816) Am J Clin Exp Urol. 2013 Dec 25;1(1):3-11. (PMID: 25110720) PLoS One. 2020 Dec 10;15(12):e0243474. (PMID: 33301465) Am J Kidney Dis. 2004 Aug;44(2):353-62. (PMID: 15264195) Clin Transplant. 2018 Dec;32(12):e13436. (PMID: 30372560) Arch Microbiol. 2020 Mar;202(2):323-327. (PMID: 31659380) J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2010 Jan;28(1):39-59. (PMID: 20390967) Mucosal Immunol. 2021 Jul;14(4):779-792. (PMID: 33542492) Epidemiol Rev. 2001;23(1):144-51. (PMID: 11588840) Nat Commun. 2018 Apr 19;9(1):1557. (PMID: 29674608) Am J Surg Pathol. 2019 Nov;43(11):1547-1553. (PMID: 31368913) Front Cell Dev Biol. 2021 Aug 20;9:710165. (PMID: 34490259) Am J Transplant. 2017 Mar;17(3):712-723. (PMID: 27597148) Genome Res. 2012 Feb;22(2):292-8. (PMID: 22009990) Am J Obstet Gynecol. 2002 Sep;187(3):581-8. (PMID: 12237631) J Clin Microbiol. 2013 Jul;51(7):2054-62. (PMID: 23596238) CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593) Genome Res. 2009 Dec;19(12):2317-23. (PMID: 19819907) Menopause. 2015 Jul;22(7):702-9. (PMID: 25535963) Cancer Med. 2019 Nov;8(16):6904-6914. (PMID: 31568654) Genome Announc. 2016 Nov 23;4(6):. (PMID: 27881533) PLoS Negl Trop Dis. 2017 Aug 9;11(8):e0005826. (PMID: 28793309) J Infect. 2014 Jan;68 Suppl 1:S2-8. (PMID: 24119828) Front Cell Infect Microbiol. 2023 Apr 05;13:1125809. (PMID: 37091677) Int Neurourol J. 2020 Mar;24(1):41-51. (PMID: 32252185) mSystems. 2021 Aug 31;6(4):e0137120. (PMID: 34282932) Front Microbiol. 2020 Oct 16;11:513305. (PMID: 33178140) J Med Microbiol. 2019 Oct;68(10):1471-1478. (PMID: 31418671) BJOG. 2020 Jan;127(2):193-201. (PMID: 31469215) APMIS. 2014 May;122(5):363-8. (PMID: 23992372) Int Urogynecol J. 2018 Feb;29(2):205-210. (PMID: 29279968) J Clin Virol. 2015 Oct;71:59-62. (PMID: 26295751) Transplantation. 2001 Feb 27;71(4):515-23. (PMID: 11258430) Urol Clin North Am. 2022 May;49(2):345-360. (PMID: 35428439) BMJ. 2014 Sep 16;349:g5264. (PMID: 25232064) Eur J Cancer. 2015 Nov;51(17):2655-64. (PMID: 26338196) Biol Sex Differ. 2018 Oct 22;9(1):45. (PMID: 30343668) |
| معلومات مُعتمدة: | T32 AI007501 United States AI NIAID NIH HHS; U01 HL146204 United States HL NHLBI NIH HHS |
| فهرسة مساهمة: | Keywords: autoimmune diseases; cancer; metabolome; urine microbiome; virome |
| تواريخ الأحداث: | Date Created: 20240126 Date Completed: 20240129 Latest Revision: 20240223 |
| رمز التحديث: | 20240223 |
| مُعرف محوري في PubMed: | PMC10808152 |
| DOI: | 10.3389/fcimb.2023.1308665 |
| PMID: | 38274734 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2235-2988 |
|---|---|
| DOI: | 10.3389/fcimb.2023.1308665 |